GBA Presents: RADIO SAVANT-!

[vanzandt]

The last few times I have done this we have sucessfuly nailed two up S&P moves and 1 down...

S&P 500 (^GSPC)--- Le's Go Up!!!!!!
SNP - SNP Real Time Price.
3,909.11-36.90 (-0.94%)<-------- GO TIME!
As of 12:08PM EDT. Market open.

Only 115 more points till we break even.

Hey you missed my perfect bottom call today on b1's thread.
Good for 80 points in one day.
Top that one.

Here comes the bounce.
3726 spx

:

 

[stonedinvestor]

to exactly where it was sept 28th when you mysteriously disappeared
I think you called for a rally that day too.

You sure are twisting things. Why is it so important for you to try and throw shade when you should just say you were right three times in a row in a short period. That first call the S&P indeed went up 90 points before cratering. Elite Traders are fast enough to get in and out; nobody is complaining-

 

[stonedinvestor]

STOCK OF THE DAY - LEVI- $14.75

Bank of America pounded the table on its bullish view of Levi Strauss & Co. (NYSE:LEVI) just ahead of the apparel company's earnings report on October 6.

Crucially for the stock, BofA thinks market concerns regarding a structural shift out of denim are overblown.

Analyst Christopher Nardone and team view LEVI as a best in class brand with a compelling strategy around the shift to direct to consumer. They also see a solid runway for LEVI to expand market share in both denim and non-denim categories.

On valuation, BofA noted that the stock is trading at an attractive multiple of 6.7X the firm's 2023 EV/EBITDA estimate, which in itself is 9% below the consensus mark.

BofA has a Buy rating on LEVI and price objective of $20 to rep more than 40% upside potential for shares.

Levi Strauss & Co. (LEVI)
NYSE - Nasdaq Real Time Price.
16.81+0.23(+1.36%)<-------------
As of 03:33PM EDT.

 

[stonedinvestor]

No 2 Buy Recommendation- Dutch Brothers-
- Buy $31.50 area<------------

-> BROS Dutch Bros Inc.

$31.15-1.27(-3.92%)12:00 PM 09/30/22
NYSE |$USD |Pre-Market:$31.75+0.60(+1.93%)4:46 AM

Back to Even -- Van I guess you have to post abou this...ZZZZZzzzzzzzzzzzz

Dutch Bros Inc. (BROS)
NYSE - Nasdaq Real Time Price.
31.54-1.30(-3.96%)
As of 03:34PM E

 

[vanzandt]

You know Van when you were commenting on VICOR price to sales or whatever I was thinking we are not going to use valuation metrics for the next move. So many stocks have PE's of 7 and 5 and no one cares... it's the idea an the timing.. as always.

Another question they gave me is relevant here--

Q- What's the difference between intrinsic and book value, and how can they deviate?

Stonedinvestor: Good question.... excellent question... well Book Value is balance sheet based, it's assets and all that crap. Intrinsic value is what I am all about- it's what you imagine the business could be worth...

So Van- I think swinging from loss to profit ought to be the metric you " scan " fornow, it's the dream baby.... not the reality.

Haha... Stoney I'm way ahead of ya buddy.

Book values easy. That's what the company is worth if liquidated and all the debts are paid.

Intrinsic value is all about cashflow. And what metric did I specifically point out on Vicor?

It's a little pricey at 54X cash-flow.
.

Read up on DCF.

 

[stonedinvestor]

2nd Stock Of The day- FLUOR- 1 year up 55% who else can say that! Van and I have been on this name since $19. It is a great IRA stock. And friendly as heck with China!

Fluor secures two projects of $2B for BASF Zhanjiang Verbund site project in China
Oct. 03, 2022 7:36 AM ET Fluor Corporation (FLR),FLRAP

• Fluor (NYSE:FLR) on Monday has secured two reimbursable engineering, procurement and construction management contracts by BASF for the ethylene oxide/ethylene glycol and infrastructure, offsites and utilities packages as part of the company’s new Verbund program in Zhanjiang, Guangdong province, China.
• The contract value to Fluor is more than $2B and was booked in the third quarter of 2022.
• The project will be led by Fluor’s Shanghai, China, office.

Up $2 since Monday afternoon!

 

[stonedinvestor]

I have the system up and running this early morning and it is scanning through thousands of stocks as I sit here and sip my coffee.. this is amazing to watch. Now I have signed some disclaimers that I did not read and I do not think I am allowed to tell you the Stock Buy recommendations of my new scanning software but I already broke the rules with Bluebird....
and I see the 2nd stock the system is rating a buy is also a biotech and one we have owned before...

So I don't see the huge crime in telling you: No 2 says Buy ABBV!

There is a nice feature with my new software package - the " why " button this gives a concise reason for buying. With BLUE it was "impending takeout". And With ABBV it's:

AbbVie

AbbVie's (NYSE:ABBV) Lupron Depot (leuprolide acetate), a gonadotropin releasing hormone, is approved for both advanced prostate cancer and endometriosis.

In Q4 2021, the company's Lupron franchise brought in $192M globally.

In January, research and advisory company Technavio said that the global leuprolide acetate market is expected to grow by ~$1B from 2021 to 2026 and achieve a ~10.4% year-over-year growth rate in 2022.

No 2's STOCKS TO BUY FOR OCT RALLY-

BLUE-

ABBV-

Unfortunately I can only access one buy per day on the plan that I signed up for... so BLUE was on Friday and ABBV today. Sunday I will ask again!

I gave ABBV out on Sat @ $136!!! --> Up$8 One week so far!!! No 2 Should Be Easy To do....



AbbVie Inc. (ABBV)
NYSE - Nasdaq Real Time Price.
144.30+2.31(+1.63%)
As of 03:39PM EDT. Market open.

• 
  

 

[stonedinvestor]

bluebird bio, Inc. (BLUE)-what is this 7 winners in two days?
No wonder I am being interviewed!!!
NasdaqGS - NasdaqGS Real Time Price.
7.03+0.24 (+3.46%)<-----------------
As of 03:43PM EDT.

 

[stonedinvestor]

There is no rally only Zuul!

By the way I meant to ask Overnight is Zuul the money transfer system banks use with all that fraud.

 

[stonedinvestor]

Upgrade of The day -

JFrog reinstated with an Overweight at JPMorgan 07:41 FROG JPMorgan analyst Pinjalim Bora reinstated coverage of JFrog with an Overweight rating and $29 price target. The analyst has a "strong fundamental positive bias" toward JFrog saying it is capitalizing on its leadership position in artifacts management and will broaden its portfolio across other areas in the DevSecOps lifecycle. JFrog offers a "very attractive" financial model, delivering over 30% revenue growth and positive free cash flow margins, Bora tells investors in a research note.

lets keep track of this one.

JFrog Ltd. (FROG)
NasdaqGS - NasdaqGS Real Time Price.
24.40+0.27 (+1.10%)
As of 03:48PM EDT. Market open.